Immunic, Inc. Receives First Regulatory Approval from German Health Authority BfArM to Initiate a …,

For more information on this clinical trial, please visit: www.clinicaltrials.gov, NCT04379271. About IMU-838. IMU-838 is an orally available, next- …, For more information on this clinical trial, please visit: www.clinicaltrials.gov, NCT04379271. About IMU-838. IMU-838 is an orally available, next- …, Read More

Scroll to Top